Cooper Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,518
| Closed | -$561K | – | 394 |
|
|
2025
Q1 | $561K | Buy |
4,518
+184
| +4% | +$22.8K | 0.07% | 226 |
|
|
2024
Q4 | $534K | Buy |
4,334
+156
| +4% | +$19.2K | 0.06% | 231 |
|
|
2024
Q3 | $465K | Buy |
4,178
+163
| +4% | +$18.2K | 0.06% | 254 |
|
|
2024
Q2 | $429K | Sell |
4,015
-17
| -0.4% | -$1.81K | 0.06% | 241 |
|
|
2024
Q1 | $486K | Buy |
4,032
+54
| +1% | +$6.5K | 0.08% | 222 |
|
|
2023
Q4 | $489K | Buy |
3,978
+2
| +0.1% | +$246 | 0.09% | 207 |
|
|
2023
Q3 | $515K | Buy |
3,976
+201
| +5% | +$26K | 0.12% | 186 |
|
|
2023
Q2 | $468K | Sell |
3,775
-46
| -1% | -$5.7K | 0.12% | 203 |
|
|
2023
Q1 | $559K | Buy |
3,821
+1,939
| +103% | +$284K | 0.15% | 155 |
|
|
2022
Q4 | $300K | Buy |
+1,882
| New | +$300K | 0.09% | 224 |
|